Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In developing rodent nervous system, although the appearance of
Thy-1
mRNA, as seen by in situ hybridisation, is in general quickly followed by the appearance of immunohistochemically detectable protein, there are certain sites where a delay of several days occurs between expression of detectable message and protein. Mouse Purkinje cells exemplify this behaviour and are the dominant
Thy-1
-expressing cell in early postnatal cerebellum, so allowing quantitative, homogenate-based methods to be used to test whether such a lag in protein expression does occur. Measurement of
Thy-1
mRNA (by slot blot) and protein (by radioimmunoassay) shows a substantial excess of
Thy-1
message, compared to protein accumulating in the tissue, during the first postnatal week, which is not found in tissues (rat cerebellum, and rat or mouse cerebrum) where no lag is apparent in appearance of
Thy-1
protein from the section-based methods. The species of
Thy-1
mRNA produced by Purkinje cells does not appear to change during development, as assessed either in terms of its size (by northern blotting) or in the heterogeneous pattern of transcription initiation sites used (assessed by
S1 nuclease
protection analysis). Appearance of
Thy-1
protein in these cells, therefore, seems to be regulated posttranscriptionally.
...
PMID:Expression of the neuronal surface glycoprotein Thy-1 does not follow appearance of its mRNA in developing mouse Purkinje cells. 134 38
Recombinant bacteriophage and cosmid clones containing the gene for the mouse
Thy-1
.2 glycoprotein were isolated and characterized. The complete sequence of the gene was determined, including a previously unidentified exon located 2.1 kb upstream of the portion of the gene encoding the
Thy-1
.2 glycoprotein. The transcriptional initiation site was located by
S1 nuclease
protection mapping in both T lymphocytes and neural cells and was found to be located immediately upstream of this exon.
S1 nuclease
protection mapping was also used to define the 3' end of the
Thy-1
.2 transcription unit, and no evidence for alternate mRNA processing was found. Thus, the mouse
Thy-1
.2 gene is 5447 base pairs in length, including promoter sequences, rather than 2094 as previously described. The mouse and rat
Thy-1
genes are highly homologous in both introns and exons. However, the mouse
Thy-1
cDNA and rat
Thy-1
cDNA differ significantly in sequence in the 5' untranslated region. This suggests that the transcriptional initiation site of the mouse and rat genes may be located at different positions within the genomic sequence and may be related to the differing tissue distribution of
Thy-1
in the two species.
...
PMID:The mouse Thy-1.2 glycoprotein gene: complete sequence and identification of an unusual promoter. 286 59